HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833
- 1 May 1999
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 57 (10) , 1147-1152
- https://doi.org/10.1016/s0006-2952(99)00026-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In Vitro Blood–Brain Barrier Permeability of Nevirapine Compared to Other HIV Antiretroviral AgentsJournal of Pharmaceutical Sciences, 1998
- HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug TransporterBiochemistry, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patientsAIDS, 1997
- Duplication and evolution of the P-glycoprotein genes in pigBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1996
- Dementia Associated with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia ComplexScience, 1988
- Bovine Brain Microvessel Endothelial Cell Monolayers as a Model System for the Blood‐Brain BarrieraAnnals of the New York Academy of Sciences, 1987